Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment

Launched by MAYO CLINIC · Mar 21, 2025

Keywords

ClinConnect Summary

This clinical trial, called "Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment," is looking to understand how effective various treatments are for children and young adults with certain hip problems, such as hip dysplasia, Legg-Calvé-Perthes disease, and avascular necrosis. The goal is to gather information about how patients feel and function both shortly after treatment and many years later.

To participate, individuals must be at least 18 years old and have been seen at Mayo Clinic for hip issues between 1975 and 2024. They also need to be willing to complete follow-up surveys. While the trial is currently active, it is not recruiting new participants at this time. Those who take part can expect to share their experiences and outcomes regarding their hip treatments, helping researchers learn more about the long-term effectiveness of these therapies.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over the age of 18 seen for a concern of hip pathology at Mayo between 1975 and 2024
• • Patients over 18 who can be contacted for follow-up and are willing to participate.
• Exclusion Criteria:
• • Patients presenting over age 18 for hip dysplasia
• • Patients who are unwilling to complete follow up surveys.